Why The Narrative Around P3 Health Partners Is Shifting After Recent Q3 Weakness And Outlook Reset [Yahoo! Finance]
P3 Health Partners Inc. - Class A (PIII)
Company Research
Source: Yahoo! Finance
fixed at 12.5%. This underscores a more nuanced narrative around risk and long term potential. While analysts wrestle with a Q3 aEBITDA miss and stronger revenue growth expectations of roughly 11.1% vs prior 6.1%, the updated target reflects a recalibration of timing rather than a complete rethink of the growth story. Read on to see how you can stay ahead of these evolving expectations and keep updated on the shifting narrative going forward. Stay updated as the Fair Value for P3 Health Partners shifts by adding it to your watchlist or portfolio . Alternatively, explore our Community to discover new perspectives on P3 Health Partners. ?? Bullish Takeaways Lake Street reiterates a Buy rating on P3 Health Partners even after a Q3 aEBITDA miss, signaling continued confidence in the long term setup despite near term noise. The firm highlights that P3 is making progress beneath the surface, suggesting that operational execution is improving even if it is not yet visible in reported
Show less
Read more
Impact Snapshot
Event Time:
PIII
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PIII alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PIII alerts
High impacting P3 Health Partners Inc. - Class A news events
Weekly update
A roundup of the hottest topics
PIII
News
- P3 Health Partners (NASDAQ:PIII) had its "neutral" rating reaffirmed by analysts at BTIG Research.MarketBeat
- P3 Expands Footprint Through Joint Venture With Commonwealth Primary Care ACOBusiness Wire
- P3 Health Partners Inc (PIII) Q3 2025 Earnings Call Highlights: Navigating Growth Amidst ... [Yahoo! Finance]Yahoo! Finance
- P3 Health Partners (NASDAQ:PIII) had its price target lowered by analysts at Lake Street Capital from $20.00 to $12.50. They now have a "buy" rating on the stock.MarketBeat
- P3 Health Partners Inc. (PIII) Q3 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
PIII
Earnings
- 8/14/25 - Miss
PIII
Sec Filings
- 11/28/25 - Form 8-K
- 11/14/25 - Form 8-K
- 11/14/25 - Form 8-K
- PIII's page on the SEC website